Helmerich & Payne, Inc. (HP) Profit Margins
Over the twelve months to 2026-06-30, Helmerich & Payne, Inc. (HP) had gross margin 31.8%, operating margin 2.3%, net margin -3.4%, free cash flow margin 7.9%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
HPHelmerich & Payne, Inc.Follow HP — free
—
Price chart with a free account
- Market cap
- 3.9B
- P/E TTM
- —
- Dividend yield
- 2.6%
- 52-week
- —
- Next earnings
- 19 Nov, in 26 days
| Line | FY2009 Sep 09 | FY2010 Sep 10 | FY2011 Sep 11 | FY2012 Sep 12 | FY2013 Sep 13 | FY2014 Sep 14 | FY2015 Sep 15 | FY2016 Sep 16 | FY2017 Sep 17 | FY2018 Sep 18 | FY2019 Sep 19 | FY2020 Sep 20 | FY2021 Sep 21 | FY2022 Sep 22 | FY2023 Sep 23 | FY2024 Sep 24 | FY2025 Sep 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — | — | — | 35.6% | 33.2% | 21.8% | 30.7% | 40.5% | 41.1% | 33.0% | 31.8% | |
| Operating margin | 33.0% | 24.1% | 27.6% | 28.9% | 28.2% | 28.3% | 21.3% | -1.6% | -9.4% | 1.3% | 0.7% | -35.0% | -35.2% | 2.2% | 19.8% | 16.6% | 0.1% | 2.3% | |
| Net margin | 19.2% | 8.3% | 17.1% | 18.4% | 21.7% | 19.0% | 13.3% | -3.5% | -7.1% | 19.4% | -1.2% | -27.9% | -26.8% | 0.3% | 15.1% | 12.5% | -4.4% | -3.4% | |
| FCF margin | 1.0% | 7.1% | 11.1% | -3.1% | 5.6% | 4.8% | 9.4% | 30.6% | -1.5% | 3.7% | 14.2% | 22.4% | 4.5% | -0.8% | 15.3% | 6.9% | 3.1% | 7.9% |
USD billions · SEC XBRL
Helmerich & Payne, Inc. — questions
- What is Helmerich & Payne, Inc.'s gross margin?
- 31.8% over the twelve months to 2026-06-30.
- What is Helmerich & Payne, Inc.'s operating margin?
- 2.3% over the twelve months to 2026-06-30.
- What is Helmerich & Payne, Inc.'s net profit margin?
- -3.4% over the twelve months to 2026-06-30.
Every figure on this page comes from Helmerich & Payne, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.